George Therapondos, MD
- Sr Physician-Section Head, Southshore Region
- 1514 Jefferson Hwy, New Orleans, LA, 70121
For additional information or to make an appointment, click here.
Overview
Overview
- Dr. George Therapondos is currently the Hepatology Section Head at the Ochsner MultiOrgan Transplant Institute. He received his medical training at the University of Edinburgh in the United Kingdom. He received his specialist certification in both internal medicine and gastroenterology and underwent clinical research training at the University of Edinburgh and the University of Toronto, Canada. He also completed a Master in Public Health at Johns Hopkins University.Dr. Therapondos was the director of the clinical trials unit of the Multi-organ Transplant Program of the University Health Network in Toronto, Canada and worked as Assistant Professor and Staff Hepatologist at Toronto General Hospital. He is a fellow of the Royal College of Physicians of Edinburgh and has continued to serve as a journal and grant reviewer for multiple journals and grant-awarding bodies.He has published on advanced liver disease and its complications, such as portal hypertension and cirrhotic cardiomyopathy. More recently, his research interests have focused on adult deceased and living donor liver transplantation and quality of life issues in liver patients.
Publications
Selected publications
-
2023Gaps in care planning and delivery for patients with liver cancer: Baseline assessment for implementation of 4R Oncology model. Journal of Clinical Oncology. 41.
-
2022Artificial intelligence to identify harmful alcohol use after early liver transplant for alcohol-associated hepatitis. American Journal of Transplantation.
-
2022Low Rates of Hepatitis B Virus Treatment Among Treatment-Eligible Patients in Safety-Net Health Systems. Journal of Clinical Gastroenterology. 56:360-368.
-
2022Patterns of Alcohol Use After Early Liver Transplantation for Alcoholic Hepatitis. Clinical Gastroenterology and Hepatology. 20:409-+.
-
2021Antiviral Therapy Reduces Risk of Cirrhosis in Noncirrhotic HBV Patients Among 4 Urban Safety-Net Health Systems. American Journal of Gastroenterology. 116:1465-1475.
-
2021Quantifying the Interaction Between Posaconazole and Tacrolimus in Liver Transplant Recipients: A Practical Approach. American Journal of Transplantation. 21:760-760.
-
2021Liver Transplantation Using Hepatitis C Virus-Viremic Donors Into Hepatitis C Virus-Aviremic Recipients as Standard of Care. Liver Transplantation. 27:548-557.
-
2020Reappraising the spectrum of AKI and hepatorenal syndrome in patients with cirrhosis. Nature Reviews Nephrology. 16:137-155.
-
2020Sustained Improvements in Markers of Liver Disease Severity After Hepatitis C Treatment. Journal of Clinical and Experimental Hepatology. 10:114-123.
-
2019Patterns and Predictors of Alcohol Use after Early Liver Transplant for Alcoholic Hepatitis.. American Journal of Transplantation. 19:561-562.
-
2019Reduction in Waitlist Time Using HCV Positive Liver Grafts in HCV Negative Recipients.. American Journal of Transplantation. 19:461-462.
-
2019Simultaneous Biliary and Liver Parenchymal Evaluation in Post Liver-Transplant Population Using Endoscopic Ultrasound-Guided Liver Biopsy and Endoscopic Retrograde Cholangiopancreatography in a Single Session Approach. American Journal of Gastroenterology. 114:S501-S502.
-
2019Underestimation of Liver Transplantation for Alcoholic Hepatitis in the National Transplant Database. Liver Transplantation. 25:706-711.
-
2019Use of HCV Positive Livers in HCV Negative Recipients: The Ochsner Experience. American Journal of Transplantation. 19:70-70.
-
2018ENDOSCOPIC ULTRASOUND-GUIDED LIVER BIOPSY: A TERTIARY CENTER EXPERIENCE. Gastrointestinal Endoscopy. 87:AB339-AB340.
-
2018Endoscopic Ultrasound-Guided Liver Biopsy Compared to Percutaneous and Transjugular Liver Biopsy: A Tertiary Center Experience. American Journal of Gastroenterology. 113:S421-S421.
-
2018Excellent Outcomes of Deceased Donor Liver Transplantation Using Grafts From Older Donors: A US Single-Center Experience. American Journal of Gastroenterology. 113:S570.
-
2018Higher early post-liver transplant mortality in recipients with severe alcoholic hepatitis versus alcoholic cirrhosis. Journal of Hepatology. 68:S808-S808.
-
2018Outcomes of Early Liver Transplantation for Patients With Severe Alcoholic Hepatitis. Gastroenterology. 155:422.
-
2018Race/ethnicity and insurance status disparities in access to direct acting antivirals for hepatitis C virus treatment. American Journal of Gastroenterology. 113:1329-1338.
-
2018Sustained and continued improvement in hepatic fibrosis beyond the first year following hepatitis C virus treatment. Journal of Hepatology. 68:S534-S534.
-
2017Beware of the Rodent: A Case Report of an Unusual Cause of Cholestatic Liver Injury. American Journal of Gastroenterology. 112:S1263-S1264.
-
2017Clinical Predictors of Biliary Obstruction at ERCP After Orthotopic Liver Transplantation (OLT). Hepatology. 66:921A-921A.
-
2017Liver Disease Management TeleECHO Improves Provider Knowledge and Care of Patients. Hepatology. 66:314A-314A.
-
2017Safety and Outcomes in 100 Consecutive Donation After Circulatory Death Liver Transplants Using a Protocol That Includes Thrombolytic Therapy. American Journal of Transplantation. 17:2155-2164.
-
2017The Utilization and Diagnostic Yield of Upper Endoscopy for Evaluation of Gastrointestinal Symptoms Within 1-Year After Liver Transplantation. American Journal of Gastroenterology. 112:S566-S566.
-
2017US Outcomes in Early Liver Transplantation for Alcoholic Hepatitis: Results from the American Consortium of Early Liver Transplantation for Alcoholic Hepatitis (ACCELERATE-AH). American Journal of Transplantation. 17:407-407.
-
2016Clearance of the hepatitis C virus without treatment occurs more often than traditionally reported. Hepatology. 64:394A-395A.
-
2016Outcomes of DCD Liver Transplantation Utilizing Donors With High Donor Risk Index. American Journal of Transplantation. 16:83-83.
-
2016Safety and Efficacy of Ledipasvir/Sofosbuvir (LS) with or without Ribavirin (RBV) for Treatment of Recurrent Hepatitis C Infection Post-Liver Transplant.. American Journal of Transplantation. 16:793-794.
-
2016Transcatheter Aortic Valve Replacement (TAVR) for Severe Aortic Stenosis as a Bridge to Liver Transplantation.. American Journal of Transplantation. 16:676-676.
-
2016Utilizing Imported Liver Grafts for HCC Recipients. American Journal of Transplantation. 16:82-82.
-
2015Health-related quality of life in long-term survivors of paediatric liver transplantation. Paediatrics and Child Health. 20:189-194.
-
2015NOVEL APPROACH FOR THE PREVENTION OF RECURRENT HEPATITIS C IN LIVER TRANSPLANT RECIPIENTS: PRELIMINARY RESULTS FROM ONGOING PHASE III TRIAL WITH CIVACIR (R). Journal of Hepatology. 62:S271-S272.
-
2015Weighing the risk: Obesity and outcomes following liver transplantation. World Journal of Hepatology. 7:1484-1493.
-
2014A Cross-Sectional Study Assessing Dietary Intake and Physical Activity in Canadian Patients with Nonalcoholic Fatty Liver Disease vs Healthy Controls. Journal of the Academy of Nutrition and Dietetics. 114:1181-1194.
-
2014Frequency and significance of IgG4 immunohistochemical staining in liver explants from patients with primary sclerosing cholangitis. International Journal of Experimental Pathology. 95:209-215.
-
2013Excellent liver retransplantation outcomes in hepatitis C-infected recipients. Clinical Transplantation. 27:E512-E520.
-
2013Liver Transplantation (OLT) Utilizing Donation after Cardiac Death (DCD) Allografts: A Single Center Experience. American Journal of Transplantation. 13:87-87.
-
2013Liver Transplantation at the Ochsner Clinic: Quality and Outcomes Improvement. The Ochsner Journal. 13:413-418.
-
2013Liver transplantation in hepatitis B core-negative recipients using livers from hepatitis B core-positive donors: A 13-year experience. Liver Transplantation. 19:611-618.
-
2013Liver transplantation in the morbidly obese: Do the outcomes justify the use of scarce organs?. Hepatology. 58:1031A-1031A.
-
2012Excellent Outcomes after Liver Retransplantation for Recurrent HCV: A Single Centre Experience. American Journal of Transplantation. 12:432-432.